Literature DB >> 7157340

Study of HLA alloantigens of the Navajo Indians of North America. II. HLA-A, B, C, DR and other genetic markers.

G M Troup, M S Schanfield, C H Singaraju, R L Harvey, J Jameson, J Capper, B Baker.   

Abstract

This report presents the antigen frequencies for HLA-A, B, C, DR, immunoglobulin, and red blood cell systems for the Navajo Indians of North America. HLA-A-B,B-C, and B-DR haplotype frequencies and significant delta values are given. These data are compared with similar data for other American Indians and major non-Indian ethnic groups. Very restricted HLA polymorphism is unique for the Navajo as well as American Indians in general and this feature has important implications with regard to disease association and transplantation.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7157340     DOI: 10.1111/j.1399-0039.1982.tb02250.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  4 in total

1.  Native American mitochondrial DNA analysis indicates that the Amerind and the Nadene populations were founded by two independent migrations.

Authors:  A Torroni; T G Schurr; C C Yang; E J Szathmary; R C Williams; M S Schanfield; G A Troup; W C Knowler; D N Lawrence; K M Weiss
Journal:  Genetics       Date:  1992-01       Impact factor: 4.562

2.  Asian affinities and continental radiation of the four founding Native American mtDNAs.

Authors:  A Torroni; T G Schurr; M F Cabell; M D Brown; J V Neel; M Larsen; D G Smith; C M Vullo; D C Wallace
Journal:  Am J Hum Genet       Date:  1993-09       Impact factor: 11.025

3.  Thyrotoxic periodic paralysis in Navajos--HLA typing.

Authors:  R Williams
Journal:  West J Med       Date:  1985-02

Review 4.  Weaving the Strands of Life (Iiná Bitł'ool): History of Genetic Research Involving Navajo People.

Authors:  Rene L Begay; Nanibaa' A Garrison; Franklin Sage; Mark Bauer; Ursula Knoki-Wilson; David H Begay; Beverly Becenti-Pigman; Katrina G Claw
Journal:  Hum Biol       Date:  2020-07-09       Impact factor: 0.553

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.